Literature DB >> 23429405

Maternal active and passive smoking and hypertensive disorders of pregnancy: risk with trimester-specific exposures.

Stephanie M Engel1, Erica Scher, Sylvan Wallenstein, David A Savitz, Elin R Alsaker, Lill Trogstad, Per Magnus.   

Abstract

BACKGROUND: The inverse association between prenatal smoking and preeclampsia is puzzling, given the increased risks of prematurity and low birthweight associated with both smoking and preeclampsia. We analyzed the Norwegian Mother and Child Birth Cohort (MoBa) to determine whether the associations varied by timing of prenatal smoking.
METHODS: We conducted an analysis of 74,439 singleton pregnancies with completed second- and third- trimester questionnaires. Active and passive smoke exposure by trimester were determined by maternal self-report, and covered the period of preconception through approximately 30 weeks' gestation. Adjusted odds ratios (ORs) and 95% confidence intervals (CIs) were calculated.
RESULTS: Rates of active smoking declined dramatically during pregnancy: for trimester 1, 23%; trimester 2, 9%; and trimester 3, 8%. Active smoking in the third trimester was associated with reduced odds of preeclampsia and gestational hypertension, with the strongest association among continuous smokers (for preeclampsia, OR= 0.57 [95% CI = 0.46-0.70]). Women who quit smoking before the third trimester had approximately the same risk of preeclampsia and gestational hypertension as nonsmokers. There was some evidence of dose-response, with the heaviest smokers (more than eight cigarettes per day) having the lowest risks of preeclampsia (0.48 [0.32-0.73]) and gestational hypertension (0.51 [0.28-0.95]). There was little evidence of an association with passive smoking exposure.
CONCLUSION: The association between smoking and preeclampsia varies substantially according to the timing and intensity of exposure. A better understanding of the biologic pathways that underlie these associations may provide important clues to the etiology of preeclampsia and the development of effective clinical interventions.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23429405      PMCID: PMC4137974          DOI: 10.1097/EDE.0b013e3182873a73

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  47 in total

1.  Contemporary concepts of the pathogenesis and management of preeclampsia.

Authors:  Kristine Y Lain; James M Roberts
Journal:  JAMA       Date:  2002-06-26       Impact factor: 56.272

2.  Cohort profile: the Norwegian Mother and Child Cohort Study (MoBa).

Authors:  Per Magnus; Lorentz M Irgens; Kjell Haug; Wenche Nystad; Rolv Skjaerven; Camilla Stoltenberg
Journal:  Int J Epidemiol       Date:  2006-08-22       Impact factor: 7.196

3.  Maternal cigarette smoking, metabolic gene polymorphisms, and preterm delivery: new insights on GxE interactions and pathogenic pathways.

Authors:  Hui-Ju Tsai; Xin Liu; Karen Mestan; Yunxian Yu; Shanchun Zhang; Yaping Fang; Colleen Pearson; Katherin Ortiz; Barry Zuckerman; Howard Bauchner; Sandra Cerda; Phillip G Stubblefield; Xiping Xu; Xiaobin Wang
Journal:  Hum Genet       Date:  2008-03-05       Impact factor: 4.132

4.  Quitting smoking during early versus late pregnancy: the risk of preeclampsia and adverse birth outcomes.

Authors:  Xu Xiong; Jun Zhang; William D Fraser
Journal:  J Obstet Gynaecol Can       Date:  2009-08

5.  Tobacco use during pregnancy and preeclampsia risk: effects of cigarette smoking and snuff.

Authors:  Anna-Karin Wikström; Olof Stephansson; Sven Cnattingius
Journal:  Hypertension       Date:  2010-03-15       Impact factor: 10.190

6.  Smoking before pregnancy and risk of gestational hypertension and preeclampsia.

Authors:  Lucinda J England; Richard J Levine; Cong Qian; Cynthia D Morris; Baha M Sibai; Patrick M Catalano; Luis B Curet; Mark A Klebanoff
Journal:  Am J Obstet Gynecol       Date:  2002-05       Impact factor: 8.661

7.  Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.

Authors:  Sharon E Maynard; Jiang-Yong Min; Jaime Merchan; Kee-Hak Lim; Jianyi Li; Susanta Mondal; Towia A Libermann; James P Morgan; Frank W Sellke; Isaac E Stillman; Franklin H Epstein; Vikas P Sukhatme; S Ananth Karumanchi
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

8.  Smoking and risk of preterm birth among predominantly Puerto Rican women.

Authors:  Amy Haskins; Shankha Mukhopadhyay; Penelope Pekow; Glenn Markenson; Elizabeth Bertone-Johnson; Elena Carbone; Renée Turzanski Fortner; Lisa Chasan-Taber
Journal:  Ann Epidemiol       Date:  2008-06       Impact factor: 3.797

9.  Smoking during pregnancy and hyperactivity-inattention in the offspring--comparing results from three Nordic cohorts.

Authors:  Carsten Obel; Karen Markussen Linnet; Tine Brink Henriksen; Alina Rodriguez; Marjo Riita Järvelin; Arto Kotimaa; Irma Moilanen; Hanna Ebeling; Niels Bilenberg; Anja Taanila; Gan Ye; Jørn Olsen
Journal:  Int J Epidemiol       Date:  2008-02-02       Impact factor: 7.196

10.  Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1.

Authors:  Melissa Cudmore; Shakil Ahmad; Bahjat Al-Ani; Takeshi Fujisawa; Heather Coxall; Kunal Chudasama; Luke R Devey; Stephen J Wigmore; Allyah Abbas; Peter W Hewett; Asif Ahmed
Journal:  Circulation       Date:  2007-03-26       Impact factor: 29.690

View more
  13 in total

1.  Differential Effect of Ambient Air Pollution Exposure on Risk of Gestational Hypertension and Preeclampsia.

Authors:  Carrie J Nobles; Andrew Williams; Marion Ouidir; Seth Sherman; Pauline Mendola
Journal:  Hypertension       Date:  2019-06-24       Impact factor: 10.190

2.  Deconstructing the smoking-preeclampsia paradox through a counterfactual framework.

Authors:  Miguel Angel Luque-Fernandez; Helga Zoega; Unnur Valdimarsdottir; Michelle A Williams
Journal:  Eur J Epidemiol       Date:  2016-03-14       Impact factor: 8.082

3.  Preeclampsia and Hypertension During Pregnancy in Areas with Relatively Low Levels of Traffic Air Pollution.

Authors:  Christian Madsen; Siri Eldevik Håberg; Geir Aamodt; Hein Stigum; Per Magnus; Stephanie J London; Wenche Nystad; Per Nafstad
Journal:  Matern Child Health J       Date:  2018-04

4.  Risk factors of hypertensive disorders among Chinese pregnant women.

Authors:  Rong Hu; Ying-Xue Li; Hai-Hong Di; Zhi-Wei Li; Chun-Hua Zhang; Xian-Ping Shen; Jun-Feng Zhu; Wei-Rong Yan
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-12-16

5.  Prevalence, Risk Factors, and Fetal and Maternal Outcomes of Hypertensive Disorders of Pregnancy: A Retrospective Study in Western Saudi Arabia.

Authors:  Ahmed Hussein Subki; Mohammed Ridha Algethami; Wejdan Mohammad Baabdullah; Majed Nasser Alnefaie; Mashael Abdullah Alzanbagi; Rawan Marzooq Alsolami; Hassan S Abduljabbar
Journal:  Oman Med J       Date:  2018-09

Review 6.  The shared pathoetiological effects of particulate air pollution and the social environment on fetal-placental development.

Authors:  Anders C Erickson; Laura Arbour
Journal:  J Environ Public Health       Date:  2014-11-26

7.  Body Mass Index, Smoking and Hypertensive Disorders during Pregnancy: A Population Based Case-Control Study.

Authors:  Thuridur A Gudnadóttir; Brian T Bateman; Sonia Hernádez-Díaz; Miguel Angel Luque-Fernandez; Unnur Valdimarsdottir; Helga Zoega
Journal:  PLoS One       Date:  2016-03-24       Impact factor: 3.240

8.  Season of Conception, Smoking, and Preeclampsia in Norway.

Authors:  Clarice R Weinberg; Min Shi; Olga Basso; Lisa A DeRoo; Quaker Harmon; Allen J Wilcox; Rolv Skjærven
Journal:  Environ Health Perspect       Date:  2017-06-29       Impact factor: 9.031

9.  Maternal Smoking during Pregnancy and Daughters' Preeclampsia Risk.

Authors:  Kristina Mattsson; Karin Källén; Anna Rignell-Hydbom; Stefan R Hansson; Thomas F McElrath; David E Cantonwine; Lars Rylander
Journal:  PLoS One       Date:  2015-12-02       Impact factor: 3.240

10.  Serum Cotinine and Adverse Cardiovascular Outcomes: A Cross-sectional Secondary Analysis of the nuMoM2b Heart Health Study.

Authors:  Lauren H Theilen; Rebecca B McNeil; Shannon Hunter; William A Grobman; Corette B Parker; Janet M Catov; Victoria L Pemberton; Deborah B Ehrenthal; David M Haas; Matthew K Hoffman; Judith H Chung; Farhana Mukhtar; Zorayr Arzumanyan; Brian Mercer; Samuel Parry; George R Saade; Hyagriv N Simhan; Ronald J Wapner; Robert M Silver
Journal:  Am J Perinatol       Date:  2021-08-06       Impact factor: 3.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.